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Summary.-Pre-treatment of hypoxic cells with misonidazole (MISO) can render
these cells more sensitive to a subsequent treatment with melphalan. Results in
this paper show that this enhancement (or chemopotentiation) depends on the contact
time and concentration of MISO, on the melphalan concentration and also on the
cultural history of the cells. Damage due to hypoxic pre-incubation in MISO can be
repaired if cells are subsequently aerated at 37°C. In contrast, for cells washed free
of MISO and then held under N2 at37°C, repair is much slower. No repair occurs when
cells are held in air at 0°C. The kinetics and extent of repair were dependent on the
cells prior culture. Thus for exponential cells repair was complete after %4 h, whereas
for plateau-phase cells and cells with prior chronic hypoxia, repair was only partially
complete after this time. Dithiothreitol was shown to protect partially against the
enhancement of melphalan toxicity. Increased cell killing is also obtained if cells
are given high concentrations of MISO (50 mM) in air during exposure to melphalan.
MISONIDAZOLE (MISO) is an effective
radiosensitizer of hypoxic cells in vitro
and in vivo (Asquith et al., 1974; Fowler
& Denekamp, 1979) and is currently
undergoing randomized, prospective clini-
cal trials. It is also preferentially cytotoxic
to hypoxic cells (Hall & Roizin-Towle,
1975; Moore et al., 1976; Stratford &
Adams, 1977).
It is known that MISO enhances anti-
tumour activity of various alkylating
agents in vivo (Rose et al., 1980; Clement
et al., 1980; Tannock, 1980a,b; Law et al.,
1981; Martin et al., 1981; Siemann,
1981; Mulcahy et al., 1981; Stephens
et al., 1981; Twentyman, 1981). En-
hancement of the cytotoxic action of
melphalan also occurs in vitro (Stratford
et al., 1980; Roizin-Towle & Hall, 1981).
Preliminary studies suggested that this
in vitro effect operates at least partly
through a hypoxia-mediated mechanism.
If enhancement of response in vivo also
involves, at least partly, hypoxia-depen-
dent processes, it offers a prospect of
obtaining selective enhancement of the
response of tumours to cytotoxic drugs.
This paper reports an investigation of
the hypothesis that hypoxia is necessary
in the pre-treatment with MISO in order
to increase the sensitivity to subsequent
treatment with melphalan in vitro. The
investigation also included a study of the
influence of the cultural history of the
cells, the duration of the hypoxic pre-
treatment, the concentration of and dura-
tion of exposure to MISO on their subse-
quent sensitivity to various doses of
melphalan.
MATERIALS AND METHODS
Cells.-Chinese hamster V79-379A cells
were grown in suspension, using methods
described previously (Stratford & Adams,
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1977). Cells were maintained routinely in
logarithmic phase at concentrations between
105 and 106/ml. The cell doubling time was
10-12 h, which required cells to be diluted
daily.
For cells given a prolonged exposure to
hypoxia, cultures were seeded at 5 x 105 ml.
Cells in full growth medium were de-aerated
in spinner flasks by passing N2 continuously
over the stirred suspension for 16 h (Smith
et al., 1980). The pH of the medium was
maintained constant at 7-4 by C02/bicarbon-
ate. Experiments showed that incubation in
prolonged hypoxia under these conditions did
not change the pH of the medium (Rajarat-
nam et al., 1981).
Under the suspension-culture conditions,
the cells attained plateau phase when their
concentration reached 1 8 x 106 ml (Stratford
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et al., 1980). They were harvested from these
unfed cultures 12 h later.
Cytotoxicity experimients. Exponential-
phase, plateau-phase and chronically hypoxic
cells were treated in suspension in 250ml
spinner flasks held in a water bath at 37°C.
MISO was added to the flasks and the cells
deoxygenated by passing N2 over the surface
of the stirred suspension. At any given time
under hypoxia, cells could be withdrawn for
treatment with melphalan in air at 37°C for
1 h. The cells were then centrifuged, resus-
pended, counted, diluted, plated in triplicate
and incubated for 7 days at 37°C. before
scoring for colony formation.
Compounds.-MISO Awas provided by
Roche Products Ltd, Welwyn Garden City,
Herts. Melphalan was obtained from Bur-
roughs Wellcome & Co. Ltd., London. and
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FIG. 1.-Exponential-phase cells (a), or plateau-phase cells (b), treated with 5mm 211S0 for 2 11 in
hypoxia at 37°C before exposure to varying concentrations of melphalan in air for I li at :37 C (0).
Cells treate(l wvith melphalan alone (O). Error bars are shown when points aie means of > 3 experi- ments.
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causes a small reduction in the surviving
fraction, to about 0 4. No correction for
this small direct cytotoxicity of MISO
has been made in calculating the surviving
fractions in this figure. Controls were those
cells, which before treatment with mel-
phalan, were held in air with or without
5mM MISO or in hypoxia alone for 2 h.
These treatments produced identical res-
ponses to melphalan. The linear propor-
tions of the survival curves (fitted by eye)
show that pre-treatment with MISO
increases the slope about 4-5-fold. This
is ingeneral agreementwith datapublished
previously (Stratford et al., 1980; Roizin-
Towle & Hall, 1981.)
Fig. lb shows data from similar experi-
ments with plateau-phase cells. Potentia-
. tion also occurs, though in this case the
enhancement ratio derived from the
linear portions of the survival curves
(2.5) is less than that for the exponential-
phase cells. This difference appears to be 2 3 4 5 due mainly to increased sensitivity of the halan concentration (vg/mI) control cells exposed to melphalan without
Iyhypoxic cells treated °C prior MISOw.
2 h in hypoxia at 370C proMSO
to varying concentrations No potentiation occurs, either in expo-
air for I h at 37°C (O). nential- or plateau-phase cells when the
ith melphalan alone (a). pre-treatment with MISO is under aerobic
periments. conditions.
was initially dissolved (1 mg/ml) in HCl/
ethanol (2: 98) before use. Dithiothreitol was
supplied by Sigma Chemical Co., London.
RESULTS
Chemopotentiation in exponential- and
plateau-phase cells
Experiments were carried out to com-
pare the enhancing effects of MISO on the
response to melphalan of both exponen-
tial- and plateau-phase cells. In both
sets ofexperiments, the cells were exposed
to 5mM MISO for 2 h under hypoxia at
37TC. The cells were then aerated and
treated with various concentrations of
melphalan for 1 h at 37TC.
Fig. Ia shows the results forexponential-
phase cells. Treatment with MISO with-
out subsequent exposure to melphalan
Effect of prolonged hypoxia before pre-
treatment with MISO
Cells were maintained in hypoxia for
16 h and then, as described above,
given 5mM MISO for a further 2 h in
hypoxia, before treatment with melphalan
for 1 h in air. Survival data are shown in
Fig. 2. The control curve shows that
chronic hypoxia slightly increases sensi-
tivity to melphalan compared with acutely
hypoxic cells and decreases it compared
with plateau-phase cells. Thus, 2 ,ug/ml
reduces survival to 10-1, 5 x lo-2 and
1-5X 10-3 for exponential, chronically
hypoxic and plateau-phase cells re-
spectively. However, although there is
only a slight difference in sensitivity to
melphalan between exponential and chron-
ically hypoxic cells, the enhancement
caused by MISO pretreatment is very
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FIG. 3. Pie-treatment of exponential-phase cells (a), or plateau-phase cells (b), -with 5mM MIS)
for different times under hypoxic conditions at 37°C before exposure to 1 ,ug/ml melphalan in ail
at 37 C (x). Survival of cells given only 5mm MISO tinder lhypoxic conditions (0). Error bars
are showrn hen points are means of > 3 experiments.
different: 4f5-fold and 2-5-fold, respec-
tively.
Pre-treatnaent with non-toxic concentrations
of MISO
The data in Figs 1 & 2 show that,
even without subsequent melphalan treat-
ment, a 2 h hypoxic exposure to 5mM
MISO can cause slight cell killing. Experi-
ments were carried out to determine
whether potentiation ofmelphalan toxicity
occurs when the pre-treatment with MISO
killed no cells. Hypoxic cultures of
either exponential- or plateau-phase cells
were exposed to 5mM MISO for up to 5 h
before treatment in air with 1 ,ug/ml of
melphalan for 1 h. The data are shown
in Fig. 3. The survival curves for cells
treated with MISO alone show that in
exponential-phase cells there is very little
loss of viability for exposure times of less
than 1' h. However, even for these short
exposure times, there is enhancement
of melphalan toxicity. The surviving
fraction of exponential-phase cells treated
for 1 h with melphalan alone is 0 4
whereas pre-treatment with MISO for
only I h before the melphalan exposure
reduces survival to 4 0 x 10-2. In plateau-
phase cells, melphalan alone is somewhat
more effective, producing a surviving
fraction of 7 x 10-2. However, pretreat-
ment with 5mM MISO for only 1 h under
hypoxic conditions, which by itself causes
no detectable cell kill, further increases
melphalan toxicity by reducing survival
to 3 x 10-3.
Effect of MISO concentration
Fig. 4 shows survival data for hypoxic
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exponential-phase cells treated
for 2 h with MISO at concentratio
30 mm before a 1 h aerobic exp
1 ,ug/ml melphalan. As expected,
trol curve shows that MISO alone
toxic at high concentrations. Hypi
treatment at such concentrations
increases the cytotoxicity of melp
Influence of delay betwveen treatm
MISO and melphalan
As part of the investigations:
mechanisms of the pre-incubatioi
experiments were carried out ii
the cells, after hypoxic treatme
MISO, were maintained in oxic or
suspension for various times befoi
ment with melphalan. Delay befi
phalan exposure has a large effect
potentiation.
Hypoxic exponential-phase cells were
exposed to 5mM MISO at 37°C for 2 h.
The cells were resuspended and maintained
in air for various times before exposure to
I jtg/ml melphalan for 1 h. The large
potentiation when the melphalan treat-
1 ment occurs immediately after exposure
to MISO progressively decreases as the
melphalan treatment is delayed. These
data are shown in Fig. 5a. After a 5h delay,
the surviving fraction is not very different
from that for cells treated with melphalan
without pre-treatment. During the course
of this work we became aware that
Roizin-Towle et al. (1982) had carried
out experiments in which they also had
delayed exposure to melphalan after
MISO pre-treatment. As reported here,
these authors found that the pre-incuba-
f tion effect was lost after 3-5 h. Also
shown in Fig. 5a are data when cells
25 30 were held at O°C between treatments.
Under these conditions no loss ofpotentia-
ontial- tion occurs on subsequent exposure to
atioins melphalan at 37°C, even after a delay of
-litions
/ug/ml up to 5 h.
totox- Similar experiments were carried out
MISO with plateau-phase cells. Again, delay
between pre-incubation with MISO and
subsequent, treatment with melphalan
reduced the cell kill, and for a 5h delay
at 37tC there was little potentiation (Fig. 5b).
ins up to Quite different results were obtained
osure to from experiments with chronically hypoxic
the con- cells. The data are shown in Fig. 6a.
is cyto- Whilst there is also substantial enhance-
oxic pre- ment, the effect of delay between pre-
3 greatly incubation and melphalan treatment is
ohalan. much less. Fig. 6b shows results from
experiments in which, after pre-incuba-
ent with tion, exponential cells were washed free
of MISO (while held at 0°C) and then
into the de-aerated and held at 37°C for various
n effect, periods before treatment with melphalan.
n which Under these conditions significant poten-
nt with tiation is still apparent 5h after exposure
hypoxic to MISO.
re treat-
ore mel- Effect of the -SH comnpound dithiothreitol
on the The addition of exogenous thiols to
cells protects against the cytotoxic action
1.21
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Fie,. P---Pre-incubation expone,ntial-phase
cells oilplateau-plhase cells (b) x-itli 35mM l\lISO in
N2 for 2 h at 37°C wvith subsequent exposture to I ,tg/ml melplialan for 1 II in air at 37°C, after
various times in air, at :37°C' (O,-) oI- at 0°C( E). EIior bars are shonii when poinit; are means
of > 3 experiments.
of MISCO (Hall & Biaglow, 1977; Koch
et al., 1979; Stratford & Gray, 1978).
The presence of cysteamine during the
pre-incubation of cells with MISO also
protects against the subsequent action of
melphalan (Roizin-Towle & Hall, 1981).
Similar experiments have been carried
out with the sulphydryl compound dithio-
threitol. This agent is relatively stable
to aerobic oxidation at physiological pH
(Cleland, 1964) and in our experiments
does not protect against the cytotoxicity
of melphalan alone. This contrasts with
the protective effect of several other thiols
against the cytotoxicity of alkylating
agents (Conners, 1966). Fig. 7 shows results
from 3 separate experiments in which
cells were treated with MISO and dithio-
threitol fori 3 h in N2 before exposure
to melphalani. Clearly the presence of the
thiol duritng the pre-incubationi reduces
the potentiation of MISO. Data from
these experiments were corrected for tox-
icity due to the individual agents alone
(detailed in the legend to Fig 7).
Potentiation uvithout hypoxic pre-treatment
Many control experiments showed that
pre-incubation of oxic cells with 5mM
MISO did not affect the cytotoxicitv
of mnelphalan, illustrating the importance
of hypoxia in the pre-incubation effect.
However, potentiation without hypoxic
pre-treatment can be found if the MISO
concentration is greatly increased. Fig. 8
shows the effect of 50mM MISO on the
cytotoxicity of melphalan when oxic
cells are exposed simultaneously to both
drugs for 1 h. 50mM MISO alone is non-
toxic in air at 37°C for a lh contact.
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FicG. 6. (a) l'Ie-incubation of clhronically hypoxic cells witlh 5mAi MNIISO in N2 for 2 hi at 37'C with
subsequent exposure to I ,ug/ml melplhalan for 1 h in air at 37°C, after various times in air. (b)
Ilre-incubation ofexponential eells with 5mI MAIISO in N2 for 2 l1 at 37 C, with subsequent exposure
to 1 ,ug/ml melphalan for I h in air at 37 C after various times in N2. Error bars are shown when
points are means of > 3 experiments.
DISCUSSION
The survival curves for hypoxic cells
exposed to MISO generally show an
initial shoulder, after which survival
decreases exponentially with contact time
(e.g. Fig. 3). This pre-exponential region
of the survival curve may be due to the
build-up of some toxic metabolite of
MISO, the accumulation of sublethal
damage (SLD) or both. Potentiation of
melphalan toxicity by hypoxic treatment
with MISO occurs in exponential-, plateau-
phase cells and in cells maintained in
hypoxia for long before MISO treatment.
The enhancement of melphalan damage
can occur with little or no cell killing due
to MISO pre-treatment alone, but the
magnitude of the enhancement depends
upon concentration and time of contact
with MISO in N2. It is only when cells
are exposed to 50mM MISO that any
enhancement of melphalan damage is
seen in an aerobic environment. These
results confirm the importance of hypoxia
for the enhancement by MISO of sub-
sequent melphalan damage in vitro.
However, the pre-incubation effect is
lost if cells are given air at 37°C for
several hours before treatment with mel-
phalan. This recovery also occurs when
cells are given split doses of MISO.
Exposure of the cells to air between
doses restores the shoulder to the survival
curve (Stratford, 1978; Taylor & Rauth,
1980). This process is dependent on
temperature and contact time, as is the
recovery from the pre-incubation effect
reported here.
These phenomena suggest the involve-
ment of intracellular repair processes and
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FIG. 7.-Pre-incubation of cells with 5mM
MISO in N2 for 3 h at 370C with (Li)
and without (A) 1mM dithiothreitol,
before exposure to varying concentra-
tions of melphalan for 1 h in air at 370C.
(0) No pre-treatment, melphalan alone;
(x) No pre-treatment, melphalan +
dithiothreitol. For clarity, survival has
been corrected for toxicity due to the
agents alone, viz: control plating efficiency
-100%, 1 mM DTT 60%, 5mM MISO
-60%, 1mM DTT + 5mM MISO-15%.
Means + s.e. from 3 replicate experiments.
the protective effect of dithiothreitol,
sulphydryl compound, supports this.
Taylor & Rauth (1980) demonstrated the
influence of SH on the shoulder of the
MISO survival curve. Exposure ofhypoxic
cells to MISO causes depletion of intra-
cellular SH (Varnes et al., 1980). Further-
more, the regeneration of these thiols
requires several hours in air at 37°C
(Bump & Brown, personal communica-
tion). However, there is evidence that
suppression of intracellular SH levels is
not the only explanation for potentiation
(Brown, 1982). Our own results suggest
C
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FIG. 8.-Simultaneous treatment of expo-
nential-phase cells with 50mM MISO and
varying concentrations of melphalan in
AIR for 1 h at 370C (x). Controls
without MISO (0). Error bars are shown
when points are means of > 3 experiments.
this also. Cells with different cultural
histories have different sensitivities to
melphalan, and also do not show the
same degree of potentiation by MISO
pre-treatment. Furthermore, these effects
do not correlate with changes in levels of
cellular non-protein sulphydryls (Smith,
1981).
There is current interest in the use of
combinations of MISO and other nitro-
heterocyclic compounds with alkylating
agents in vivo. The enhancement of
tumour response may be a manifestation
of the pre-incubation effects seen in vitro,
though alternative mechanisms have been
suggested (Law et al., 1981; Workman &
Twentyman, 1982). In most instances
MISO/cytotoxic-drug combinations show
greater effects on tumours than on some
normal tissues. Moreover, Spooner et al.
(1982) showed that chemopotentiation in
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the Lewis lung tumour is greater in
tumours weighing 200 mg than in those
only weighing 2 mg. This suggests that a
physiological property of a tumour (hy-
poxia) is important in the expression of
the MISO-induced potentiation. The in
vitro evidence reported here strongly
supports the proposal that a hypoxia-
mediated phenomenon is also important
in chemo-potentiation of alkylating agent
in vivo.
Christine Williamson is thanked for excellent
technical assistance and the MRC and NCI (grant
no. NCI-CM-17485) for financial support.
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